Cyrus Mozayeni follows ADC ‘beacon’ to Pheon CEO role; BeiGene loses business chief to Teva

Cyrus Mozayeni

Cyrus Mozayeni has been around the biotech business long enough not to be fazed when things don’t go as expected.

Soon after he closed his last startup in April, Vedere Bio II — a gene therapy biotech born out of another that…
Click here to view original post

Advertisement — Advertise with Biotech Networks